Compugen SVP Zurit Levine Exercises Options and Sells Shares Under 10b5-1 Plan

Zurit Levine, Senior Vice President of Business Development at Compugen Ltd (CGEN), executed multiple transactions on April 10, 2026, pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025. Levine exercised two sets of stock options: 1,125 shares at $0.8292 per share and 2,000 shares at $1.15 per share, acquiring a total of 3,125 ordinary shares. Concurrently, Levine sold 3,125 ordinary shares at a weighted average price of $2.564 per share, with transactions ranging from $2.50 to $2.60. Following these transactions, Levine's direct holdings decreased to 29,375 ordinary shares. The options exercised had vesting schedules tied to continued service, with expiration dates in 2032 and 2033. This filing represents a routine insider transaction executed under a pre-established trading plan.